SCOPUS 정보 검색 플랫폼 - 논문 보기

메뉴 건너뛰기

Cancer Biology and Therapy

Volumn 14, Issue 10, 2013, Pages 881-882

Ceramide in the prostate

(1) Dent, Paul a

a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE (United States)

Author keywords

c Myc; Cell signaling; Ceramide; Histone acetyl transferase; Inhibitor 2 of protein phosphatase 2A; Protein phosphatase 2A; Tumor suppressor lipid

Indexed keywords

CERAMIDE; I2PP2A ENZYME; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATASE; UNCLASSIFIED DRUG;

DRUG MECHANISM; ENZYME INHIBITION; HISTONE ACETYLATION; HUMAN; NOTE; PROTEIN EXPRESSION;

C-MYC; CELL SIGNALING; CERAMIDE; HISTONE ACETYL TRANSFERASE; INHIBITOR 2 OF PROTEIN PHOSPHATASE 2A; PROTEIN PHOSPHATASE 2A; TUMOR SUPPRESSOR LIPID;

ANTINEOPLASTIC AGENTS; CERAMIDES; HISTONE CHAPERONES; HUMANS; MALE; PROSTATIC NEOPLASMS; TRANSCRIPTION FACTORS;

EID: 84885223009 PISSN: 15384047 EISSN: 15558576 Source Type: Journal
DOI: 10.4161/cbt.26212 Document Type: Note

Times cited : (6)

References (6)

1
- 0024397415
- The structure and regulation of protein phosphatases
- Cohen P. The structure and regulation of protein phosphatases. Annu Rev Biochem 1989; 58:453-508; PMID:2549856; http://dx.doi.org/10.1146/annurev. bi.58.070189.002321 (Pubitemid 19172978)
- (1989) Annual Review of Biochemistry , vol.58 , pp. 453-508
- Cohen, P.¹

2
- 84881106542
- Structure regulation and pharmacological modulation of PP2A phosphatases
- PMID:23860660
- Lambrecht C, Haesen D, Sents W, Ivanova E, Janssens V. Structure, Regulation, and Pharmacological Modulation of PP2A Phosphatases. Methods Mol Biol 2013; 1053:283-305; PMID:23860660; http://dx.doi.org/10.1007/978-1-62703- 562-0-17
- (2013) Methods Mol Biol , vol.1053 , pp. 283-305
- Lambrecht, C.¹ Haesen, D.² Sents, W.³ Ivanova, E.⁴ Janssens, V.⁵

3
- 84885210143
- Targeting inhibitor 2 of protein phos-phatase 2A as a therapeutic strategy for prostate cancer treatment
- PMID:24025258
- Mukhopadhyay A, Tabanor K, Chaguturu R, Aldrich JV. Targeting inhibitor 2 of protein phos-phatase 2A as a therapeutic strategy for prostate cancer treatment. Cancer Biol Ther 2013; 14:962-72; PMID:24025258; http://dx.doi.org/ 10.4161/cbt.25943
- (2013) Cancer Biol Ther , vol.14 , pp. 962-972
- Mukhopadhyay, A.¹ Tabanor, K.² Chaguturu, R.³ Aldrich, J.V.⁴

4
- 33644977905
- Sphingolipid targets in cancer therapy
- PMID:16505092
- Modrak DE, Gold DV, Goldenberg DM. Sphingolipid targets in cancer therapy. Mol Cancer Ther 2006; 5:200-8; PMID:16505092; http://dx.doi.org/10. 1158/1535-7163.MCT-05-0420
- (2006) Mol Cancer Ther , vol.5 , pp. 200-208
- Modrak, D.E.¹ Gold, D.V.² Goldenberg, D.M.³

5
- 84871968824
- Sphingosine analogue drug FTY720 targets I2PP2A/SET and mediates lung tumour suppression via activation of PP2A-RIPK1-dependent necroptosis
- PMID:23180565
- Saddoughi SA, Gencer S, Peterson YK, Ward KE, Mukhopadhyay A, Oaks J, Bielawski J, Szulc ZM, Thomas RJ, Selvam SP, et al. Sphingosine analogue drug FTY720 targets I2PP2A/SET and mediates lung tumour suppression via activation of PP2A-RIPK1-dependent necroptosis. EMBO Mol Med 2013; 5:105-21; PMID:23180565; http://dx.doi. org/10.1002/emmm.201201283
- (2013) EMBO Mol Med , vol.5 , pp. 105-121
- Saddoughi, S.A.¹ Gencer, S.² Peterson, Y.K.³ Ward, K.E.⁴ Mukhopadhyay, A.⁵ Oaks, J.⁶ Bielawski, J.⁷ Szulc, Z.M.⁸ Thomas, R.J.⁹ Selvam, S.P.¹⁰

6
- 84863498954
- Sorafenib and pemetrexed toxicity in cancer cells is mediated via SRC-ERK signaling
- PMID:22673740
- Bareford MD, Hamed HA, Allegood J, Cruickshanks N, Poklepovic A, Park MA, Ogretmen B, Spiegel S, Grant S, Dent P. Sorafenib and pemetrexed toxicity in cancer cells is mediated via SRC-ERK signaling. Cancer Biol Ther 2012; 13:793-803; PMID:22673740; http://dx.doi.org/10.4161/cbt.20562
- (2012) Cancer Biol Ther , vol.13 , pp. 793-803
- Bareford, M.D.¹ Hamed, H.A.² Allegood, J.³ Cruickshanks, N.⁴ Poklepovic, A.⁵ Park, M.A.⁶ Ogretmen, B.⁷ Spiegel, S.⁸ Grant, S.⁹ Dent, P.¹⁰

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.